EcoDrugPlus

Ribosomal Protein L31

Ensembl ID : ENSPNYG00000015985
Gene Symbol: RPL31
3 Cross references
651 Possible Orthologues:

Ribosomal Protein L35

Ensembl ID : ENSPNYG00000005682
Gene Symbol: RPL35
3 Cross references
274 Possible Orthologues:

Ribosomal Protein L35a

Ensembl ID : ENSPNYG00000023240
Gene Symbol: RPL35A
3 Cross references
452 Possible Orthologues:

Ribosomal Protein L37

Ensembl ID : ENSPNYG00000004836
Gene Symbol: RPL37
3 Cross references
424 Possible Orthologues:

Ribosomal Protein L37a

Ensembl ID : ENSPNYG00000016933
Gene Symbol: RPL37A
3 Cross references
420 Possible Orthologues:

Ribosomal Protein L38

Ensembl ID : ENSPNYG00000004306
Gene Symbol: RPL38
1 Cross references
194 Possible Orthologues:

Ribosomal Protein L39

Ensembl ID : ENSPNYG00000009831
Gene Symbol: RPL39
3 Cross references
68 Possible Orthologues:

Ribosomal Protein L4

Ensembl ID : ENSPNYG00000014038
Gene Symbol: RPL4
3 Cross references
341 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSPNYG00000021372
Gene Symbol: RPL5
4 Cross references
455 Possible Orthologues:

Ribosomal Protein L5

Ensembl ID : ENSPNYG00000002219
Gene Symbol: RPL5
4 Cross references
469 Possible Orthologues:

Ribosomal Protein L6

Ensembl ID : ENSPNYG00000008108
Gene Symbol: RPL6
3 Cross references
486 Possible Orthologues:

Ribosomal Protein L7

Ensembl ID : ENSPNYG00000001214
Gene Symbol: RPL7
3 Cross references
492 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).